Browse > Article

A Case of Glycogen Storage Disease Type III Diagnosed by Gene Panel Sequencing  

Kim, Seong Wan (Department of Pediatrics, Ajou University Hospital, Ajou University School of Medicine)
Jang, Ju Young (Department of Pediatrics, Ajou University Hospital, Ajou University School of Medicine)
Lee, Jang Hoon (Department of Pediatrics, Ajou University Hospital, Ajou University School of Medicine)
Sohn, Young Bae (Department of Medical Genetics, Ajou University Hospital, Ajou University School of Medicine)
Jang, Ja-Hyun (Green Cross Genome)
Publication Information
Journal of The Korean Society of Inherited Metabolic disease / v.20, no.1, 2020 , pp. 24-28 More about this Journal
Abstract
Type III Glycogen storage disease (Type III GSD, OMIM#232400) is a genetic metabolic disorder in which undigested glycogen accumulates in the organs due to lack of glycogen debranching enzyme caused by AGL mutation. The clinical symptoms of type III GSD include hepatomegaly, delayed growth, hypoglycemia and muscle weakness. These clinical symptoms are similar to those of other types of GSD, making it difficult to distinguish clinically. The authors report a case of type III GSD diagnosed by gene panel sequencing. A 11-month old male patient was presented with hepatomegaly. In liver biopsy, glycogen was accumulated in hepatocytes, suggesting GSDs. For differential diagnosis of types of GSD, gene panel sequencing for GSDs was performed. As a result, two novel pathogenic compound heterozygous variants: c.311_312del (p.His104Argfs*15) and c.3314+1G>A in AGL were detected and the patient was diagnosed as type III GSD. After diagnosis, he started dietary treatment with cornstarch, and has been free from complications. After two years, two same variants were also identified in the chorionic villous sampling of the pregnant mother, and the fetus was diagnosed as type III GSD. Gene panel sequencing is useful for diagnosis of disease which is indistinguishable by clinically and has high genetic heterogeneity, such as GSD. After diagnosis, familial genetic analysis can provide adequate genetic counseling and rapid diagnosis.
Keywords
Glycogen storage disease type III; AGL; Gene panel sequencing; Familial mutation analysis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Kishnani PS, Austin SL, Arn P, Bali DS, Boney A, Case LE, et al. Glycogen storage disease type III diagnosis and management guidelines. Genet Med 2010;12:446-63.   DOI
2 Liu W, Madsen NB, Braun C, Withers SG. Reassessment of the catalytic mechanism of glycogen debranching enzyme. Biochemistry 1991;30:1419-24.   DOI
3 Shin YS. Glycogen storage disease: clinical, biochemical, and molecular heterogeneity. Semin Pediatr Neurol 2006;13:115-20.   DOI
4 Goldstein JL, Austin SL, Boyette K, Kanaly A, Veerapandiyan A, Rehder C, et al. Molecular analysis of the AGL gene: identification of 25 novel mutations and evidence of genetic heterogeneity in patients with Glycogen Storage Disease Type III. Genet Med 2010;12:424-30.   DOI
5 Rousseau-Nepton I, Okubo M, Grabs R, Consortium FC, Mitchell J, Polychronakos C, et al. A founder AGL mutation causing glycogen storage disease type IIIa in Inuit identified through whole-exome sequencing: a case series. CMAJ 2015;187:E68-E73.   DOI
6 Zimmermann A, Rossmann H, Bucerzan S, Grigorescu-Sido P. A Novel Nonsense Mutation of the AGL Gene in a Romanian Patient with Glycogen Storage Disease Type IIIa. Case Rep Genet 2016;2016:8154910.   DOI
7 Wang Z, Liu X, Yang BZ, Gelernter J. The role and challenges of exome sequencing in studies of human diseases. Front Genet 2013;4:160.   DOI
8 Shen J, Bao Y, Liu HM, Lee P, Leonard JV, Chen YT. Mutations in exon 3 of the glycogen debranching enzyme gene are associated with glycogen storage disease type III that is differentially expressed in liver and muscle. J Clin Invest 1996;98:352-7.   DOI
9 Sentner CP, Vos YJ, Niezen-Koning KN, Mol B, Smit GP. Mutation Analysis in Glycogen Storage Disease Type III Patients in the Netherlands: Novel Genotype-Phenotype Relationships and Five Novel Mutations in the AGL Gene. JIMD Rep 2013;7:19-26.   DOI
10 Ko JS, Moon JS, Seo JK, Yang HR, Chang JY, Park SS. A mutation analysis of the AGL gene in Korean patients with glycogen storage disease type III. J Hum Genet 2014;59:42-5.   DOI
11 Mogahed EA, Girgis MY, Sobhy R, Elhabashy H, Abdelaziz OM, El-Karaksy H. Skeletal and cardiac muscle involvement in children with glycogen storage disease type III. Eur J Pediatr. 2015;174:1545-8.   DOI
12 Dagli AI, Zori RT, McCune H, Ivsic T, Maisenbacher MK, Weinstein DA. Reversal of glycogen storage disease type IIIa-related cardiomyopathy with modification of diet. J Inherit Metab Dis 2009;32 Suppl 1:S103-6.
13 Cosme A, Montalvo I, Sanchez J, Ojeda E, Torrado J, Zapata E, et al. [Type III glycogen storage disease associated with hepatocellular carcinoma]. Gastroenterol Hepatol 2005;28:622-5.   DOI
14 Ben Chehida A, Ben Messaoud S, Ben Abdelaziz R, Ben Ali N, Boudabous H, Ben Abdelaziz I, et al. Neuromuscular Involvement in Glycogen Storage Disease Type III in Fifty Tunisian Patients: Phenotype and Natural History in Young Patients. Neuropediatrics 2019;50:22-30.   DOI
15 Yang BZ, Ding JH, Brown BI, Chen YT. Definitive prenatal diagnosis for type III glycogen storage disease. Am J Hum Genet 1990;47:735-9.